Browsing by Author "Ibrahim Yildiz"

Now showing items 1-2 of 2

Can basal neutrophil/lymphocytes ratio predict clinical outcome of melanoma patients?

Bayoğlu, İbrahim Vedat; Gozde Kurtel; Ahmet Alacacioglu; Varım, Ceyhun; Ibrahim Yildiz; Yuksel Kucukzeybek; Ahmet Dirican; Lutfiye Demir; Murat Akyol; Mustafa Oktay Tarhan (AMER SOC CLINICAL ONCOLOGY, 2015)
Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study

Bilir, Cemil; Ibrahim Yildiz; Ahmet Bilici; Mahmut Ucar; Veli Berk; Yasar Yildiz; Ozan Yazici; Goksen Inanc Imamoglu; Nuri Karadurmus; Kezban Nur Pilanci; Erkan Arpaci; Ozgur Tanriverdi; Ebru Karci; Suleyman Temiz; Erdinc Nayir; Esin Oktay; Pinar Dal; Ibrahim Petekkaya; Varım, Ceyhun; Cinemre, Hakan (TAYLOR & FRANCIS INC, 2017)

Background: There are insufficient predictive markers for renal cell carcinoma (RCC). Methods: A total of 308 metastatic RCC patients were analyzed retrospectively. Results: The increased hemoglobin (Hb) group had significantly ...